Insulin-like growth factor 1 receptor
Insulin-like growth factor 1 receptor (IGF1R) is a receptor that binds insulin-like growth factor 1 (IGF1) with high affinity. This receptor is a type of tyrosine kinase receptor, which is activated by a phosphorylation process. The IGF1R plays a crucial role in growth and development, particularly during fetal development, and it continues to have important functions in adults.
Structure
The IGF1R is a transmembrane receptor that is present on the cell surface. It is composed of two alpha subunits and two beta subunits, which are linked by disulfide bonds. The alpha subunits are located extracellularly and are responsible for ligand binding, while the beta subunits span the membrane and have an intracellular domain with tyrosine kinase activity.
Function
Upon binding of the ligand IGF1, the IGF1R undergoes autophosphorylation, which activates the receptor's intrinsic tyrosine kinase activity. This leads to the phosphorylation of several intracellular substrates, initiating a cascade of intracellular signaling events. These signals regulate various cellular processes, including cell proliferation, cell differentiation, and apoptosis.
The IGF1R is also involved in longevity, as studies have shown that reduced function of this receptor can lead to increased lifespan in some organisms.
Clinical significance
Abnormalities in the IGF1R can lead to various health problems. Overexpression of the receptor has been associated with several types of cancer, including breast cancer, lung cancer, and colorectal cancer. In these cases, the IGF1R promotes cell proliferation and inhibits apoptosis, contributing to tumor growth and progression.
On the other hand, mutations that impair the function of the IGF1R can lead to growth retardation and developmental delays, as seen in conditions such as Laron syndrome.
See also
References

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
